1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARS PHARMACEUTICALS INC
ARS Pharmaceuticals Inc XNAS: SPRY
10.30 0.31 (3.10%)
1.6M
XNAS Volume

XNAS 02 Feb, 2026 4:16 PM (EST)

Watchlist

Portfolio

Alert

ARS Pharma Inc - SPRY - stock price prediction, stock price target, analyst ratings from 6 analysts

ARS Pharma Inc has a share price target of US$ 28, revenue growth forecast of -8.3%, and profit growth estimate of -2270.8% for FY25, based on top 6 analyst calls.